verve therapeutics - Search News

Order byBest matchMost fresh

Eli Lilly Buys Verve Therapeutics

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

· 52m · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

· 2h

Verve Therapeutics' Lifeline: Eli Lilly's $1.3 Billion Bet On Cardiovascular Gene Therapy (Upgrade)

· 4h

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve’s stock VERV soared 76% in premarket trading on Tuesday. If the gains hold through the trading session, they’ll eclipse the previous record one-day gain of 28% for the company’s stock on Oct. 31...

· 7h

Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve

SchaeffersResearch.com · 5h

Biotech Stock Surging on Billion-Dollar Buyout

19mon MSN

These Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More

Stocks declined Tuesday and oil prices rose as Israel and Iran continued to exchange missile attacks and as hopes for a quick resolution to the conflict faded.These stocks were on the move Tuesday:Sunrun sank 40%,

PharmExec1h

Eli Lilly to Acquire Verve Therapeutics for $1 Billion

With acquisition of Verve Therapeutics, Eli Lilly aims to advance next-generation cardiovascular care through one-time gene editing treatments.

Explore more